Liver transplantation is the only treatment of the end-stage liver disease. We present the outcomes of our 144 pediatric liver transplant cases. We performed 148 pediatric liver transplants between December 2006 and April 2013. The 92% of the cases were transplanted from living donors. Mean age was 4,5 years (0,31-17,95 years of age). Biliary Atresia (26,3%) and Progressive Familial Intrahepatic Cholestasis (19,4%) were the most common causes of the end stage liver disease. Nine (6,25%) of the transplantations were performed due to fulminant hepatic failure. Median hospital and intensive care unit stay were 18 and 4 days, respectively. Mean follow-up period was 23 months. The main complications were gastrointestinal bleeding (12,5%), portal vein thrombosis (6,9%), biliary leak (6,2%), biliary stricture (4,1%), and intestinal perforation (3,4%). Overall survival rate was 87%. Living donor liver transplantation is a life saving and safe procedure in the situation of low pediatric organ donation.